Amid the opioid scandal, what next for Purdue Pharma and the Sackler family?

Brasil Notícia Notícia

Amid the opioid scandal, what next for Purdue Pharma and the Sackler family?
Brasil Últimas Notícias,Brasil Manchetes
  • 📰 TheEconomist
  • ⏱ Reading Time:
  • 10 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 7%
  • Publisher: 92%

Our weekly podcast on the markets, the economy and the world of business

OXYCONTIN, a pain medication, is at the eye of the opioid crisis in America. The drug is manufactured by Purdue Pharma, a company owned by members of the Sackler family.

How similar is this storm to that which the tobacco industry faced in the 1990s? Also: the fading fortunes of European banks and New York City’s $100bn congestion problem. Simon Long hosts.

Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

TheEconomist /  🏆 6. in US

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

OxyContin-maker Purdue Pharma and Sackler family agree to pay $270 million to settle opioid caseOxyContin-maker Purdue Pharma and Sackler family agree to pay $270 million to settle opioid caseThe case against Purdue and other manufacturers was scheduled to go to trial in May. Accusations against the Stamford, Connecticut-based company included downplaying the addiction risk of opioids while overstating the benefits.
Consulte Mais informação »

Purdue Pharma agrees to $270 million settlement in Oklahoma opioid casePurdue Pharma agrees to $270 million settlement in Oklahoma opioid casePurdue Pharma agrees to $270 million settlement in Oklahoma opioid case via ReutersTV
Consulte Mais informação »

OxyContin maker Purdue Pharma reaches $270 million settlement related to opioid crisisOxyContin maker Purdue Pharma reaches $270 million settlement related to opioid crisisOxyContin maker Purdue Pharma reaches $270 million settlement related to opioid crisis, with $200 million earmarked for an opioid center at Oklahoma State University.
Consulte Mais informação »

With $270 million settlement, Purdue Pharma starts paying for the opioid crisisWith $270 million settlement, Purdue Pharma starts paying for the opioid crisisOn a new Post Reports: katiezez on a big blow for opioid maker Purdue Pharma, AmyEGardner on Florida’s amendment giving felons the right to vote, and MrDanZak on how monarch butterflies, climate change and immigration are connected.
Consulte Mais informação »

New York AG sues Purdue Pharma, J&J, McKesson in case against opioid manufacturers and distributorsNew York AG sues Purdue Pharma, J&J, McKesson in case against opioid manufacturers and distributorsThe New York Attorney General is filing new allegations against Purdue Pharma and the Sackler Family, according to The Wall Street Journal.
Consulte Mais informação »

N.Y. accuses opioid maker Purdue of illegal fund transfers to SacklersN.Y. accuses opioid maker Purdue of illegal fund transfers to SacklersPurdue Pharma LP fraudulently transferred funds to members of the wealthy Sackle...
Consulte Mais informação »

More lawsuits are hanging over the billionaire family that made its fortune in opioidsMore lawsuits are hanging over the billionaire family that made its fortune in opioidsSeveral members of the Sackler family own and control Purdue Pharma, the pharmaceutical giant facing a string of lawsuits over its alleged role in the crisis.
Consulte Mais informação »



Render Time: 2025-03-04 11:55:36